Omicron Is a Bigger Risk for the Young, Medical Data Shows
(Bloomberg) -- The omicron variant may be more dangerous for children than earlier coronavirus strains, a study of hospitalization data from one of South Africa's biggest medical insurance programs showed.
Data from the 56,164 Covid-19-related hospital admissions among the more than 2 million beneficiaries of the Government Employees Medical Scheme found that the admission rate for children under the age of four was 49% higher during the omicron wave than for delta. It was also higher than during the infection surges driven by the original virus and the beta variant, according to the data analyzed by the National Institute for Communicable Diseases.
In addition, admissions were 25% higher for those aged 4 to 18 than in the delta wave, although lower than for beta, it showed.
The trend among children contrasts with the data for adults where the omicron wave caused the lowest admission rate of any of the four variants that have led to major infection surges in South Africa.
“Persons under the age of 18 are responsible for an increasingly large proportion of identified Covid-19 infections and are associated with an increasingly high case-admission rate,” the NICD said in its report on Wednesday. “This may possibly suggest that the young are being more commonly impacted by omicron in contrast to the adult population.”
Still, the results may be skewed by the fact that until early November children between 12 and 17 couldn't get Covid-19 vaccines in South Africa and those below 12 aren't eligible for the shots, the NICD said. Older age groups in the country are proportionally more vaccinated than younger adults.
| Read More: |
|---|
| Omicron Deaths in South Africa Peaked at 15% of Delta Wave |
| Omicron Study in S. Africa Points to End of Acute Pandemic |
The study also found:
- The average age of those testing positive for Covid-19 during the omicron wave was 38.5, compared with 40.8 during the delta surge, 45.6 during the beta wave and 43 in the original surge.
- Over all age groups, only 15.4% of those infected during the omicron wave went to the hospital. The corresponding numbers were 19.3% for delta, 28.4% for beta and 21.4% for the original virus.
©2022 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.